May 1, 2023
“Year on year, there are a growing number of myopia management options available, and it can be difficult for practicing clinicians to keep pace with the evolving evidence base. The white papers bring together leading experts around the world to provide consensus and summarize the latest evidence to make it easily accessible and readily available for practicing clinicians to implement in practice,” said Dr. Nina Tahhan, Program Director of the International Myopia Institute, and Director of Clinical Research at BHVI. “The IMI is incredibly committed to developing and disseminating the latest evidence-based research for all to benefit from.”
The first two series of IMI white papers were released in 2019 and 2021, and they provided consensus and clinical management guidance for myopia development and management. The third series of white papers highlight evidence around onset, progression, and management of myopia in less typical young adult and pediatric populations, the role of the choroid in eye growth control and myopia management, and a detailed anatomical paper on non-pathological ocular tissue changes observed in moderate to high myopia. In addition, the series includes a report on the results of an international survey of practitioners on myopia management attitudes and strategies in clinical practice, and a digest that updates the latest evidence from topics covered in previous editions.
“We have brought together the leading experts in myopia research from across the globe once again to ensure that clinicians have the latest information on myopia control to provide the best service to their patients, to highlight areas where more research is required, and to guide the ophthalmic industry in the development of products needed for the future,” said Professor James Wolffsohn, IMI Chief Scientific Officer.